Board of Advisors
The dean's Board of Advisors is a group of approximately 25 high-level public and private sector leaders invited by the dean to help the School reach its advancement goals in government and community relations, professional and industry relations, communications, and resource development. Members advise, advocate, and open doors on the School's behalf. They meet annually as a group and individually advise the dean and faculty members throughout the year.
-
Mary Anne Koda-Kimble, PharmD
Professor and Dean
UCSF School of Pharmacy
San Francisco, CA -
Alice E. Till, PhD
Chair, Board of Advisors
Vice President, Science Policy and Technical Affairs
PhRMA
Washington, DC -
Lorie G. Rice, MPH
Administrator, Board of Advisors
Associate Dean, External Affairs
UCSF School of Pharmacy
San Francisco, CA
Board members
-
Victoria Au, MS
Director
ProActive Learning Ltd.
Hong Kong -
Bruce Bodaken
Chairman, President and Chief Executive Officer
Blue Shield of California
San Francisco, CA -
Philip P. Burgess, RPh, MBA
National Director of Pharmacy Affairs
Walgreen Company
Deerfield, IL -
Albert L. Carver, RPh
Vice President, Pharmacy Strategy and Operations
Kaiser Permanente
Downey, CA -
Gary W. Cleary, PhD
President and Chief Technical Officer
Corium International, Inc.
Redwood City, CA -
Eric T. Herfindal, PharmD, MPH
President and Chief Executive Officer
National Oncology Alliance, Inc.
San Rafael, CA -
Nancy U. Kamei, PharmD
Strategic Investment Manager, Biotechnology
Intel Capital
Kentfield, CA -
Donald T. Kishi, PharmD
President
Pharmacy Alumni Association
UCSF School of Pharmacy
San Francisco, CA -
Michael D. Maves, MD, MBA
Executive Vice President and Chief Executive Officer
American Medical Association
Chicago, IL -
Garry E. Menzel, PhD, MBA
Managing Director, Head of Global Biotechnology Investment Banking
Goldman, Sachs & Company
San Francisco, CA -
David Miller, PhD
Vice President, Global Health Outcomes
GlaxoSmithKline
Research Park Triangle, NC -
Michael L. Ryan, PharmD
Vice President and General Manager, Corporate Accounts
Amgen, Inc.
Thousand Oaks, CA -
Daniel V. Santi, MD, PhD
Chairman and Chief Executive Officer
Kosan Biosciences
Hayward, CA -
George A. Scangos, PhD
President and Chief Executive Officer
Exelixis, Inc.
South San Francisco, CA -
Marilyn Standifer Shreve
Senior Director, eSales/eHealth
Astra Zeneca
Kentfield, CA -
Catherine Angell Sohn, PharmD
Vice President, Worldwide Business Development and Strategic Alliance
GlaxoSmithKline
Philadelphia, PA -
Linda Suydam, DPA
President
Consumer Healthcare Products Association
Washington, DC -
Fred W. Telling, PhD
Vice President, Corporate Policy and Strategic Management
Pfizer, Inc.
New York, NY -
Raymond J. Townsend, PharmD
President
Wasatch Health Outcomes, Inc.
Park City, UT -
Roger L. Williams, MD
Executive Vice President and CEO
US Pharmacopeia
Rockville, MD
Ex-officio members
-
Robert L. Day, PharmD
Associate Dean
UCSF School of Pharmacy -
Ken A. Dill, PhD
Associate Dean, Research
UCSF School of Pharmacy -
Robert M. Duca, MBA
Associate Dean, Administration and Finance
UCSF School of Pharmacy -
Kathy M. Giacomini, PhD
Professor and Chair, Department of Biopharmaceutical Sciences
UCSF School of Pharmacy -
Thomas L. James, PhD
Professor and Chair, Department of Pharmaceutical Chemistry
UCSF School of Pharmacy -
Susan M. Levings, MS
Associate Dean, Planning and Communications
UCSF School of Pharmacy -
Marie Parfitt-Pattie
Director of Development and Alumni Relations -- School of Pharmacy
Office of University Development and Alumni Relations -
Lloyd Y. Young, PharmD
Professor and Chair, Department of Clinical Pharmacy
UCSF School of Pharmacy
Go to: Participants

